Image For Activity Cover
Heart Failure Seminar: Focus on Novel and Emerging Myocarditides: Recognition and Management
2024 HFSA Heart Failure Seminar: Focus on Novel and Emerging Myocarditides: Recognition and Management
The 2024 HFSA HF Seminar on Novel and Emerging Myocarditides, featuring expert presentations on critical topics in epidemiology, recognition, and management. This seminar brings together leading experts to delve into the latest advancements and practical insights essential for healthcare professionals at the forefront of cardiac care.
Learning Objectives

At the conclusion of this activity, learners will be better able to: 

  • Recognize the changes in myocarditis epidemiology over the past century that impact the clinical spectrum of disease. 
  • Describe the clinical, imaging and histologic predictors of death, ventricular arrhythmia and heart transplantation in acute myocarditis 
  • Differentiate the treatment of lymphocytic myocarditis from giant cell myocarditis, immune checkpoint inhibitor myocarditis, and cardiac sarcoidosis 
Target Audience
This activity is intended for cardiologists, interventional cardiologists, primary care physicians, cardiac surgeons, internists, nurse practitioners, physician assistants, nurses, pharmacists, and other health care providers who care for patients with heart failure.
Content Outline
Epidemiology of Emerging Myocardities
(Long Covid, HIV, and Beyond)

Leslie Cooper, MD, FHFSA

Recognition and Dianosis
(Novel Biomarkers and Imaging)
Wilson Tang, MD, FHFSA

Management and Treatment
Craig Beavers, PharmD

Panel Discussion
Related Resource(s)
pdf document link
View complete information.
Important (Date(s)
Originally recorded August 13, 2024.
Summary
Availability: On-Demand
Expires on Aug 16, 2025
Cost: Member: $0.00
Non-Member: $59.00
Credit Offered:
1.5 CME Credits
1.5 CNE Credits
1.5 CPE Credits
Recommended
Powered by Oasis.